Robert W. Ashworth
General Counsel at ATYR PHARMA, INC.
Profile
Robert W.
Ashworth's current job is Vice President-Regulatory Affairs at aTyr Pharma, Inc. Dr. Ashworth's former jobs include Vice President-Global Regulatory Affairs at NPS Pharmaceuticals, Inc., Vice President-Regulatory Affairs at Otsuka Pharmaceutical Development & Commercialization, Inc., Senior Vice President-Regulatory Quality & CMC at OncoSec Medical, Inc., and SVP-Regulatory Officer, Quality & Compliance at Advaxis, Inc. Dr. Ashworth's education includes a doctorate degree from Massachusetts Institute of Technology and an undergraduate degree from St. John's University.
Robert W. Ashworth active positions
| Companies | Position | Start |
|---|---|---|
| ATYR PHARMA, INC. | General Counsel | 2021-10-05 |
Former positions of Robert W. Ashworth
| Companies | Position | End |
|---|---|---|
| ONCOSEC MEDICAL INCORPORATED | General Counsel | - |
| AYALA PHARMACEUTICALS, INC. | Compliance Officer | 2017-12-31 |
Otsuka Pharmaceutical Development & Commercialization, Inc.
 Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | General Counsel | - |
| NPS PHARMACEUTICALS, INC. | General Counsel | - |
Training of Robert W. Ashworth
| Massachusetts Institute of Technology | Doctorate Degree |
| St. John's University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ATYR PHARMA, INC. | Health Technology |
| ONCOSEC MEDICAL INCORPORATED | Health Services |
| Private companies | 3 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Otsuka Pharmaceutical Development & Commercialization, Inc.
Otsuka Pharmaceutical Development & Commercialization, Inc. Pharmaceuticals: MajorHealth Technology Part of Otsuka Holdings Co., Ltd., Otsuka Pharmaceutical Development & Commercialization, Inc. is a healthcare company that was founded in 2007. The private company is based in Princeton, NJ. The company is driven by their purpose and defined by their beliefs. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Robert W. Ashworth
